Mercedes
Salgado Fernández

Foto de Mercedes

Foto de Complexo Hospitalario Universitario de Ferrol

Complexo Hospitalario Universitario de Ferrol

Ferrol, España

Publications in collaboration with researchers from Complexo Hospitalario Universitario de Ferrol (4)

2021

Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain
BMC Cancer, Vol. 21, Núm. 1

2019

Efficacy and safety of FOLFIRI/aflibercept in second-line treatment of metastatic colorectal cancer in a real-world population: Prognostic and predictive markers
Cancer Medicine, Vol. 8, Núm. 3, pp. 882-889

2014

Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: Final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)
BMC Cancer, Vol. 14, Núm. 1

2010

A retrospective observational study on the safety and efficacy of first-line treatment with bevacizumab combined with FOLFIRI in metastatic colorectal cancer
British Journal of Cancer, Vol. 103, Núm. 10, pp. 1536-1541

CRIS project developed in collaboration with Fundación Dialnet (University of La Rioja)